HUMULIN 30/70 biosynthetic human 30% neutral 70% isophane insulin 100IU/mL injection 10mL vial Australia - English - Department of Health (Therapeutic Goods Administration)

humulin 30/70 biosynthetic human 30% neutral 70% isophane insulin 100iu/ml injection 10ml vial

eli lilly australia pty ltd - insulin, quantity: 100 iu/ml - injection, suspension - excipient ingredients: zinc oxide; water for injections; phenol; sodium hydroxide; glycerol; metacresol; protamine sulfate; hydrochloric acid; dibasic sodium phosphate heptahydrate - for the treatment of insulin dependent diabetic patients.

HUMULIN NPH human insulin 100IU/mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

humulin nph human insulin 100iu/ml injection vial

eli lilly australia pty ltd - insulin, quantity: 100 iu/ml - injection, suspension - excipient ingredients: sodium hydroxide; glycerol; metacresol; zinc oxide; phenol; dibasic sodium phosphate heptahydrate; protamine sulfate; hydrochloric acid; water for injections - this product accepted for registration as 'currently supplied' at the time of commencement of the act. humulin is indicated for the treatment of insulin-dependent diabetic patients.

Posilac 500 mg Suspension Philippines - English - FDA (Food And Drug Administration)

posilac 500 mg suspension

eli lilly (philippines), inc.; distributor: eli lilly (philippines), inc. - sometribove zinc - suspension - 500 mg

OLUMIANT baricitinib 4 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

olumiant baricitinib 4 mg film-coated tablet blister pack

eli lilly australia pty ltd - baricitinib, quantity: 4 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; magnesium stearate; mannitol; microcrystalline cellulose; polyvinyl alcohol; titanium dioxide; macrogol 3350; purified talc; lecithin; iron oxide red - rheumatoid arthritis,olumiant is indicated for the treatment of moderate to severe active rheumatoid arthritis (ra) in adult patients who have responded inadequately, or who are intolerant, to one or more dmards.,olumiant can be taken as monotherapy or in combination with cdmards, including methotrexate (mtx).,atopic dermatitis,olumiant is indicated for the treatment of moderate to severe atopic dermatitis (ad) in adult patients who are candidates for systemic therapy.,alopecia areata,olumiant is indicated for the treatment of severe alopecia areata (aa) in adult patients in whom other treatments have failed or are not appropriate and no spontaneous improvement is observed (see section 5.1 pharmacodynamic properties; clinical trials).

OLUMIANT baricitinib 2 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

olumiant baricitinib 2 mg film-coated tablet blister pack

eli lilly australia pty ltd - baricitinib, quantity: 2 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; magnesium stearate; mannitol; microcrystalline cellulose; polyvinyl alcohol; titanium dioxide; macrogol 3350; purified talc; lecithin; iron oxide red - rheumatoid arthritis,olumiant is indicated for the treatment of moderate to severe active rheumatoid arthritis (ra) in adult patients who have responded inadequately, or who are intolerant, to one or more dmards.,olumiant can be taken as monotherapy or in combination with cdmards, including methotrexate (mtx).,atopic dermatitis,olumiant is indicated for the treatment of moderate to severe atopic dermatitis (ad) in adult patients who are candidates for systemic therapy.,alopecia areata,olumiant is indicated for the treatment of severe alopecia areata (aa) in adult patients in whom other treatments have failed or are not appropriate and no spontaneous improvement is observed (see section 5.1 pharmacodynamic properties; clinical trials).

EFFIENT 10 mg Film-Coated Tablet Philippines - English - FDA (Food And Drug Administration)

effient 10 mg film-coated tablet

eli lilly phils inc - prasugel (as hydrochloride) - film-coated tablet - 10 mg

Humulin 70/30 100 IU/mL Suspension for Injection f(SC) Philippines - English - FDA (Food And Drug Administration)

humulin 70/30 100 iu/ml suspension for injection f(sc)

eli lilly phils inc - recombinant human insulin (70% isophane / 30% soluble) - suspension for injection f(sc) - 100 iu/ml

EVOXAC- cevimeline hydrochloride capsule United States - English - NLM (National Library of Medicine)

evoxac- cevimeline hydrochloride capsule

stat rx usa llc - cevimeline hydrochloride (unii: p81q6v85np) (cevimeline - unii:k9v0cdq56e) - cevimeline hydrochloride 30 mg - cevimeline is indicated for the treatment of symptoms of dry mouth in patients with sjögren’s syndrome. cevimeline is contraindicated in patients with uncontrolled asthma, known hypersensitivity to cevimeline, and when miosis is undesirable, e.g., in acute iritis and in narrow-angle (angle-closure) glaucoma.

HUMULIN R Israel - English - Ministry of Health

humulin r

eli lilly israel ltd, israel - insulin (human) - solution for injection - insulin (human) 100 iu/ml - insulin (human) - insulin (human) - for the treatment of patients with diabetes mellitus who require insulin for the maintenance of glucose homeostasis

HUMULIN 7030 Israel - English - Ministry of Health

humulin 7030

eli lilly israel ltd, israel - insulin (human) - suspension for injection - insulin (human) 100 iu/ml - insulin (human) - insulin (human) - for the treatment of patients with diabetes mellitus who require insulin for the maintenance of glucose homeostasis